All about health

Hapbee Technologies, Inc. ("Hapbee" or the "Company"), the digital wellness technology company is pleased to confirm that it has completed a non-brokered private placement of units of the Company ("Units") for aggregate gross proceeds to the...

Cognivia, an innovative AI company dedicated to reshaping pharmaceutical and biotech clinical research through cutting edge AI-ML algorithms, proudly announces a significant investment milestone. Vesalius Biocapital IV, SFPIM (Société Fédérale de...

LGI Healthcare Solutions, a Canadian leader in healthcare IT, is proud to announce its new strategic partnership with Cegid, a leader in cloud business management solutions for professionals in Human Resources. This collaboration delivers a fully...

The First Foods Justice Breastfeeding Certification Program for Doulas, is centered on reclaiming breastfeeding education and bringing lactation support to communities most impacted by low breastfeeding rates. The program was first announced at the...

The Midwest Institute for Nonsurgical Therapy (MINT), a leading provider of minimally invasive medical procedures, is proud to announce the introduction of Prostate Artery Embolization (PAE) for the treatment of Benign Prostatic Hyperplasia (BPH),...

More than three years after establishment, Stramsen Biotech, Inc, is one of the leading plant-based biotech start-up companies in the world. After initial valuation in 2023, it has now officially been valued at $6.5 Billion, according to a...

Happy Fruit, renowned for its delicious and nutritious fruit gummies, proudly unveils its latest breakthrough: THCV-infused gummies. Harnessing the therapeutic potential of Tetrahydrocannabivarin (THCV), these gummies promise to transform the...

The federal Liberal-NDP coalition government recently announced it would work with the provinces to fund universal prescription drug benefits for contraceptives and diabetes medications. It is the first step toward a national pharmacare program that...

D2M Biotherapeutics, Inc. (D2M), a clinical stage biotech company focused on developing innovative therapies in treating  Immunological-Inflammatory diseases and cancers,   today announced that the first patient had been dosed in a phase 1,...

Neogen® Corporation announced today that it has formed a genomics relationship with Performance Food Group , making the company the official genomics provider for the food group's PathProven service....

The "GSK3528869A Bepirovirsen Market Size, Forecast, and Emerging Insight - 2032" report has been added to ResearchAndMarkets.com's offering. The report provides comprehensive insights about GSK3528869A Bepirovirsen for chronic hepatitis B in the...

As part of its ongoing commitment to building industry-leading fitness and wellness curriculum and enhancing student experiences while also prioritizing environmental sustainability, the International Sports Sciences Association (ISSA) has announced...

The Rock Creek Foundation, a staple of support for individuals with intellectual disabilities and mental illness in Montgomery County, MD and the Greater Washington region, will host its 50th Anniversary Gala on Thursday, April 18th, from 6pm to...

HealthSignals is proud to announce the attainment of a national group purchasing agreement for Telehealth with Premier, Inc. Effective 03/01/2024, this agreement empowers Premier members to benefit from specially negotiated pricing and terms for...

Evofem Biosciences, Inc.  announced today that the United States Patent and Trademark Office (USPTO) issued to the Company a Notice of Allowance for patent application 17/823,020 entitled, "Compositions and Methods for Enhancing...

Plant pathology or phytopathology is a scientific study discipline focusing on plant diseases caused by pathogens and environmental factors. In China, the teaching of plant pathology commenced in 1910. Despite its relatively brief history, China's...

Schrödinger, Inc. , whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today reported that on April 15, 2024, the company granted (i) non-statutory stock options to purchase 3,600 shares of...

RenovoRx, Inc. ("RenovoRx" or the "Company") , a clinical-stage biopharmaceutical company developing novel precision oncology therapies based on a local drug-delivery platform, today announced that, in light of its recent successful fundraising...

Cerus Corporation announced today that its first quarter 2024 financial results will be released on Thursday, May 2, 2024, after the close of the stock market. The Company will host a conference call and webcast at 4:30 P.M. ET that afternoon,...

The companionship and support of a pet can be a lifeline for people diagnosed with cancer. However, caring for a pet while also trying to care yourself can be extremely challenging. CancerCare's Pet Assistance & Wellness (PAW) Program recently...

...

Core Solutions, Inc., (Core) is pleased to announce that Easterseals Midwest has selected its Cx360 electronic health record (EHR) solution. This selection reflects the organization's ongoing commitment to helping individuals with intellectual and...

?     Results from the Phase 3 SELECT-GCA study showed 46 percent of patients with giant cell arteritis (GCA) who were treated with upadacitinib (RINVOQ®; 15 mg) with a 26-week steroid taper regimen achieved sustained remission from week 12 through...

Initial Therapeutics Inc., a life sciences company discovering and developing new small-molecule therapeutics with a novel platform to selectively modulate translation of pathogenic proteins in the ribosome, has appointed Peter DiLaura as President...

Natural Shrimp, Inc. (the "Company" or "NSI"), a Biotechnology Aquaculture Company that has developed and patented the first seafood-focused commercially operational RAS (Recirculating Aquaculture System), today announced it has completed at the end...

In this free webinar, gain insights into the most effective tools, technologies and strategies for biologics discovery and development. Attendees will learn about stable bulk cultures (SBC)-based platforms, which represent a paradigm shift for...

?     Next-generation non-cardiotoxic anthracycline Annamycin with notable signs of clinical efficacy in AML in combination with Cytarabine achieves preliminary CRc rate of 60% in 2nd line AML subjects in a European clinical trial ?     There are...

Soligenix, Inc. ("Soligenix" or the "Company"), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, today announced the pricing of its public offering...

NRx Pharmaceuticals, Inc. , ("NRx Pharmaceuticals" or the "Company"), a clinical-stage biopharmaceutical company, today announced the pricing of its underwritten public offering of shares of its common stock at a public offering price of $3.30 per...

DarioHealth Corp. ("Dario" or the "Company"), a leader in the global digital health market, announced today two new contracts to provide integrated chronic condition management solutions for two employers beginning in the second quarter of 2024....